Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Johnson & Johnson › Marc André Ceusters
MC

Marc André Ceusters — 11 Patents

Johnson & Johnson: 9 patents #1,101 of 7,810Top 15%
MAMallinckrodt: 2 patents #164 of 489Top 35%
Brussels, BE: #104 of 1,743 inventorsTop 6%
Overall (All Time): #435,149 of 4,157,543Top 15%
11 Patents All Time
Marc André Ceusters has been granted 11 US patents while listed as an inventor at Johnson & Johnson. The first was granted in 1999 and the most recent in July 2024. Marc André Ceusters ranks #435,149 of 4,157,543 US inventors in our database (top 10.5%). Patent records list Marc André Ceusters in Brussels, BE.

Patents per Year

Patents granted per year, 1999 to 2024Bar chart with a peak of 2 patents in 2001.peak 21999: 1 patents19992001: 2 patents20012003: 1 patents20032004: 1 patents20042007: 1 patents20072017: 1 patents20172020: 1 patents20202021: 1 patents20212022: 1 patents20222024: 1 patents2024

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12048696 Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use Brian D. KLEIN, Hilde Lavreysen, Stefan Maria Christiaan Pype, Roy E. Twyman, Nancy Eulalie Sylvain Van Osselaer +3 more 2024-07-30 $360,219,000
11369606 Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use Brian D. KLEIN, Hilde Lavreysen, Stefan Maria Christiaan Pype, Roy E. Twyman, Nancy Eulalie Sylvain Van Osselaer +4 more 2022-06-28 $842,080,000
11103506 Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use Brian D. KLEIN, Hilde Lavreysen, Stefan Maria Christiaan Pype, Roy E. Twyman, Nancy Eulalie Sylvain Van Osselaer +3 more 2021-08-31 $182,300,000
10537573 Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use Brian D. KLEIN, Hilde Lavreysen, Stefan Maria Christiaan Pype, Roy E. Twyman, Nancy Eulalie Sylvain Van Osselaer +4 more 2020-01-21 $78,078,000
9708315 1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors Jose Maria Cid-Nunez, Andrés Avelino Trabanco-Suárez, Hilde Lavreysen 2017-07-18 $103,524,000
7208503 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives Raymond A. Stokbroekx, Marcel Jozef Maria Van der Aa, Marcel G. M. Luyckx, Marc Willems, Robert W. Tuman 2007-04-24 $130,153,000
6833369 Angiogenesis inhibiting 5-substituted-1,2,4,-thiadiazolyl derivatives Raymond A. Stokbroekx, Marcel Jozef Maria Van der Aa, Marcel G. M. Luyckx, Marc Willems, Robert W. Tuman 2004-12-21 $343,789,000
6602873 Angiogenesis inhibiting thiadiazolyl pyridazine derivatives Raymond A. Stokbroekx, Marcel Jozef Maria Van der Aa, Marcel G. M. Luyckx, Marc Willems, Robert W. Tuman 2003-08-05 $205,646,000
6265407 Angiogenesis inhibiting thiadiazolyl pyridazine derivatives Raymond A. Stokbroekx, Marcel Jozef Maria Van der Aa, Marcel G. M. Luyckx, Marc Willems, Robert W. Tuman 2001-07-24 $261,661,000
6194386 Labelled peptide compounds John Mertens, Dirk Tourwe 2001-02-27
5952464 Labelled peptide compounds John Mertens, Dirk Tourwe 1999-09-14 $17,121,000

Frequent Collaborators

Hilde Lavreysen5 shared
Jose Maria Cid-Nunez5 shared
Andrés Avelino Trabanco-Suárez5 shared
Brian D. KLEIN4 shared
H. Steven WHITE4 shared
Nancy Eulalie Sylvain Van Osselaer4 shared

Nearby-Ranked Inventors

Ya-Ching Chang11
Hermann Lubbert11
Alexander WAITE11
Mehrad Mehr11
Matthew J. Purdey11
Nishtha Madaan11
Ian C. Richards11
Chad Huffman11
Lifeng Fan11